HBV'de Tedavi - EKMUD

Sorun Enfeksiyonlarda Yaklaşım ve Tedavi:
Batı Nil Virüsü
53. Petersen LR, Roehring TJ. West Nile virus: a reemerging
global pathogen. Emerg Infect Dis 2001;4:611-4.
54. Pino LAM, Blitvich JB, Ale FAJ, Puerto IF, Bianco MJ,
Marleen LN, et al. Serologic evidence of West Nile virus
infection in horses, Yucatan State, Mexico. Emerg Infect
Dis 2003;9:857-9.
55. Prince HE, Tobler LH, Yeh C, et al. Persistence of West Nile
virus-specific antibodies in viremic blood donors. Clin
Vaccine Immunol 2007;14:1228-30.
56. Radda A. Antibodies against group A and B arboviruses
in domestic animals from Turkey. EU Tıp Fak Mec
1971;10:227-9.
57. Sampathkumar P. West Nile virus: epidemiology, clinical
presentation, diagnosis and prevention. Mayo Clin Proc
2003;78:1137-44.
58. Schweitzer BK, Kramer WL, Sambol AR, Meza JL, Hinrichs
SH, Iwen PC. Geographic factors contributing to a high
seroprevalence of West Nile virus-specific antibodies in
humans following an epidemic. Clin Vaccine Immunol
2006;13:314-8.
59. Serter D. Arbovirüs enfeksiyonları. Turkiye Klinikleri J Int
Med Sci 2006;2:25-41.
60. Serter D. Arbovirüs enfeksiyonlarında tanı ilkeleri. Vektör
Kaynaklı İnfeksiyonlar paneli, XIII. Türk Klinik Mikrobiyoloji
ve İnfeksiyon Hastalıkları Kongresi, 14-18 Mart 2007,
Antalya.
61. Serter D. Present status of arbovirus sero-epidemiology in
the Aegean region of Turkey. In: Vesenjak-Hirjan J,
Caliserh C (eds). Arboviruses in the Mediterranean
Countries. Germany: Stutgart Gustav Fischer Verlag,
1980:155-61.
62. Shahar A, Lustig S, Akov Y, Schneider P, Levin R. Different
pathogenicity of encephalitic togaviruses in organotypic
cultures of spinal cord slices. J Neurosci Res 1990;25:345-
52. doi: 10.1002/jnr.490250311.
63. Shi PY, Kramer LD. Molecular detection of West Nile virus
RNA. Expert Rev Mol Diagn 2003;3:357-66.
212
64. Shi PY, Wong SJ. Serologic diagnosis of West Nile virus
infection. Expert Rev Mol Diagn 2003;3:733-41.
65. Shimoni Z, Niven J, Pitlick S, Bulvik S. Treatment of West
Nile virus encephalitis with intravein immunoglobulin
(Letters). Emerg Infect Dis 2001;7:759.
66. Spataro P, Scoglio ME, Di Pietro A, et al. Seroprevalence
study on the diffusion of the West Nile virus among
blood donors, healthcare workers, jockeys, grooms and
fowlers, veterinary surgeons and hunters in Messina
(Italy). J Prev Med Hyg 2008;49:22-5.
67. Tardei G, Ruta S, Chitu V, et al. Evaluation of immunoglobulin
M (IgM)and IgG enzyme immunoassays in serological
diagnosis of West Nile infection. J Clin Microbiol
2000;38:2232-9.
68. Tosun S. Batı Nil virüsü enfeksiyonunda klinik ve tedavi. III.
Türkiye Zoonotik Hastalıklar Sempozyumu (1-2 Kasım
2010), Ankara, Türkiye, 2010:161-5.
69. Wang W, Sarkodie F, Danso K, et al. Seroprevalence of
West Nile virus in Ghana. Viral Immunol 2009;22:17-22.
70. Weiss D, Carr D, Kellachan J, et al. Clinical findings of
West Nile virus infection in hospitalized patients, New
York and New Jersey 2000. Emerg Infect Dis 2001;7:
654-9.
71. Wong SJ, Demarest VL, Boyle RH, et al. Detection of
human anti-flavivirus antibodies with a West Nile virus
recombinant antigen microsphere immunoassay. J Clin
Microbiol 2004;42:65-72.
72. Yazıcı Z. Batı Nil virusu infeksiyonu. İnfeksiyon Dergisi
(Turkish Journal of Infection) 2005;19:139-43.
73. Zeller HG, Schuffenecker I. West Nile virus: an overview
of its spread in Europe and the Mediterranean basin in
contrast to its spread in the Americas. Eur J Clin Microbiol
Infect Dis 2004;23:147-56.
3. Türkiye EKMUD Bilimsel Platformu